Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Financial Statements Details - Accrued and Other Liabilities (Details)

v3.25.3
Condensed Consolidated Financial Statements Details - Accrued and Other Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Accrued and other liabilities    
Accrued legal and accounting fees $ 2,201 $ 251
Accrued incentive compensation 1,085 1,555
Accrued payroll and benefits 392 170
Accrued short-term interest payable   3,039
Accrued clinical liabilities   306
Income taxes payable in connection with Pulmokine acquisition   280
Other accrued liabilities 456 151
Total $ 4,134 $ 5,752